Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Career
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Learning
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Career
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Learning
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

Hematology (blood)

  • Article

    Anti-Xa Monitoring During Therapeutic LMWH Use Leads to Frequent Dose Changes Without Clear Evidence of Improved Clinical Outcomes

    September 2, 2026

    Clinical Question: In patients receiving therapeutic low-molecular-weight heparin (LMWH), does anti-Xa monitoring with subsequent dose adjustment improve bleeding or thrombotic outcomes? Background:...

  • Article

    IV Iron Administration During Acute Infection Does Not Worsen Outcomes and Is Associated with Improved Survival and Hemoglobin Recovery

    September 2, 2026

    Clinical Question: In hospitalized adults with iron-deficiency anemia (IDA) and concurrent acute infection, does IV iron administration improve clinical outcomes or worsen the infection? Background:...

  • Article

    Personalized Hemodynamic Resuscitation Using Capillary Refill Time

    August 3, 2026

    Clinical Question: Does personalized resuscitation improve outcomes in early septic shock when targeting capillary refill compared to usual care? Background: Resuscitation in early septic shock is...

  • Article

    When Less is More: How to Provide Less Anticoagulant and Antiplatelet Treatment to Improve Outcomes

    July 1, 2026

    As hospitalists, we are often trained to err on the side of doing more, especially in the ways we have historically approached anticoagulation and antiplatelet therapies. Faced with the competing...

  • Article

    Evaluation of Optimal Duration of DAPT After PCI When Stratified by Bleeding Risk

    June 18, 2026

    Mount Sinai Med-Lit Review Clinical question: What is the optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) placement...

  • Article

    Extended Low-Dose Apixaban After Provoked VTE Reduces Recurrence in Selected Patients

    June 18, 2026

    Mount Sinai Med-Lit Review Clinical question: Among patients with provoked venous thromboembolism (VTE) and ongoing risk factors, does extending anticoagulation with low-dose apixaban reduce...

  • Article

    Response to Blood Culture Shortage Promotes High Value Care

    May 1, 2026

    Clinical question: Do diagnostic stewardship interventions in times of crisis lead to sustained change in blood-culture ordering practices? Background: It is estimated that a third of all blood...

  • Article

    Anticoagulation and Antiplatelet Therapy in Patients with AF and Atherosclerosis

    April 6, 2026

    CLINICAL QUESTION: In patients with atherosclerotic disease and concurrent atrial fibrillation, does adding antiplatelet therapy to oral anticoagulation improve net clinical outcomes compared with...

  • Article

    Octreotide LAR Reduced Transfusion Needs and Endoscopic Interventions in Angiodysplasia-Related Anemia

    November 3, 2025

    CLINICAL QUESTION: Does octreotide long-acting release (LAR) reduce transfusion requirements in patients with angiodysplasia-related anemia? BACKGROUND: Angiodysplasias frequently cause refractory...

  • Article

    Therapeutic-Dose Anticoagulation Shortened the Duration of ACS in Sickle Cell Disease Without Increasing Major Bleeding Risk

    September 3, 2025

    Clinical question: Does therapeutic-dose anticoagulation, compared to prophylactic dosing, improve clinical outcomes in adults with sickle cell disease hospitalized for acute chest syndrome...

1 2 3 … 15Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • Cookie Preferences